Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» XEN901
XEN901
Neurocrine is beefing up its pipeline, splurging $50M on rights to an epilepsy drug
Endpoints
Mon, 12/2/19 - 10:35 am
Neurocrine
epilepsy
Xenon
XEN901